Skip to content

    Cancer Health Center

    Font Size

    ‘Cautious Optimism’ Over Cancer Vaccine

    Vaccine Treats Breast, Cervical Cancers by Revving Up Immune System to Curb Tumor Growth
    WebMD Health News
    Reviewed by Louise Chang, MD

    April 14, 2008 (San Diego) -- Vaccines that rev up the immune system to seek out and destroy tumor cells are showing promise for the treatment of cervical and breast cancer.

    One vaccine significantly cut deaths in women with an aggressive type of breast cancer. A second vaccine curbed or stopped the growth of tumors in women with cervical cancer.

    Unlike the vaccine that helps prevent cervical cancer in healthy women, these vaccines are designed to help people who already have cancer.

    Tumor cells often grow and spread because the body doesn't recognize them as foreign. The vaccines aim to re-educate the immune system to recognize cancer cells as alien invaders that need to be attacked and annihilated.

    Both studies were presented here at the annual meeting for the American Association for Cancer Research (AACR).

    Vaccine Targets HER2/neu

    The breast cancer vaccine targets a protein called HER2/neu that is associated with aggressive tumors. In high amounts, the protein speeds up tumor growth and the risk of death.

    About 25% of women with breast cancer fall into this category. In the new study, the vaccine reduced their risk of death by 50%.

    Importantly, the vaccine worked even better in women who had lower but still elevated levels of HER2/neu, says researcher Linda C. Benavides, MD, of Brooke Army Medical Center in San Diego.

    None of the women in this category -- which accounts for about half of breast cancer patients -- died.

    If the vaccine pans out in future study, "we'll have an option for the largest subset of breast cancer patients, who really haven't been considered before," Benavides tells WebMD.

    She notes that women with high expression of Her2/neu can benefit from targeted therapies, such as Herceptin. But the only options for women with lower expression are conventional chemo, surgery, or radiation, she says.

    Breast Cancer Vaccine Cuts Deaths

    The study involved 165 women, about one-third of whom had high levels of HER2/neu. The rest had lower or intermediate levels.

    All the women had been treated for breast cancer but were disease-free at the time of the study.

    1 | 2 | 3

    Today on WebMD

    Colorectal cancer cells
    New! I AM Not Cancer Facebook Group
    Lung cancer xray
    See it in pictures, plus read the facts.
    sauteed cherry tomatoes
    Fight cancer one plate at a time.
    Ovarian cancer illustration
    Real Cancer Perspectives
    Jennifer Goodman Linn self-portrait
    what is your cancer risk
    colorectal cancer treatment advances
    breast cancer overview slideshow
    prostate cancer overview
    lung cancer overview slideshow
    ovarian cancer overview slideshow
    Actor Michael Douglas